HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
1.380
+0.240 (21.05%)
At close: Jan 16, 2026, 4:00 PM EST
1.378
-0.002 (-0.14%)
After-hours: Jan 16, 2026, 7:51 PM EST
HCW Biologics Market Cap
HCW Biologics has a market cap or net worth of $3.73 million as of January 16, 2026. Its market cap has decreased by -81.24% in one year.
Market Cap
3.73M
Enterprise Value
9.44M
1-Year Change
-81.24%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since the IPO on July 20, 2021, HCW Biologics's market cap has decreased from $285.20M to $3.73M, a decrease of -98.69%. That is a compound annual growth rate of -61.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 3.73M | 42.18% |
| Dec 31, 2025 | 2.62M | -86.80% |
| Dec 31, 2024 | 19.87M | -54.91% |
| Dec 29, 2023 | 44.07M | -35.84% |
| Dec 30, 2022 | 68.69M | -17.13% |
| Dec 31, 2021 | 82.89M | -70.94% |
| Jul 20, 2021 | 285.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |